Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 1
1975 5
1976 4
1977 1
1978 1
1979 2
1981 3
1984 1
1985 2
1986 1
1987 2
1989 6
1990 4
1991 3
1992 4
1993 3
1994 5
1995 2
1996 1
1998 5
1999 2
2000 2
2001 1
2002 1
2003 3
2004 1
2005 3
2006 2
2008 2
2011 3
2012 3
2013 2
2014 3
2015 2
2016 1
2017 1
2018 1
2020 2
2021 4
2022 2
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Congenital Adrenal Hyperplasia.
Murphy A, Kearns C, Sugi MD, Sweet DE. Murphy A, et al. Among authors: sweet de. Radiographics. 2021 Jul-Aug;41(4):E105-E106. doi: 10.1148/rg.2021210118. Radiographics. 2021. PMID: 34197246 No abstract available.
Osteosarcomatosis.
Hopper KD, Moser RP Jr, Haseman DB, Sweet DE, Madewell JE, Kransdorf MJ. Hopper KD, et al. Among authors: sweet de. Radiology. 1990 Apr;175(1):233-9. doi: 10.1148/radiology.175.1.2315487. Radiology. 1990. PMID: 2315487
Pulmonary Light-Chain Deposition Disease.
Sweet DE, Wheeler CA, Kearns C, Marquis KM. Sweet DE, et al. Radiographics. 2022 Sep-Oct;42(5):E145-E146. doi: 10.1148/rg.220123. Epub 2022 Jul 22. Radiographics. 2022. PMID: 35867594 No abstract available.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
Oral and dermatologic manifestations of HIV infection.
Jewell ME, Sweet DE. Jewell ME, et al. Among authors: sweet de. Postgrad Med. 1994 Oct;96(5):105-8, 111, 114-6. doi: 10.1080/00325481.1994.11945910. Postgrad Med. 1994. PMID: 7937409 Review.
Epithelioid hemangioendothelioma and related lesions.
Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM. Weiss SW, et al. Among authors: sweet de. Semin Diagn Pathol. 1986 Nov;3(4):259-87. Semin Diagn Pathol. 1986. PMID: 3303234 Review.
Bone tumor dynamics: an orthopedic pathology perspective.
Johnson LC, Vinh TN, Sweet DE. Johnson LC, et al. Among authors: sweet de. Semin Musculoskelet Radiol. 2000;4(1):1-15. doi: 10.1055/s-2000-6851. Semin Musculoskelet Radiol. 2000. PMID: 11061688 Review.
100 results